Taken together, our results show that M2 macrophage markers and TIM3/galectin-9/CEACAM1 expression levels are increased in thyroid cancer tissues, thereby supporting our in vitro findings. The gene discussed is LGALS9; the disease is thyroid gland carcinoma.